Senior Medical Advisor
Neurology
Dr. Ann Marie M. Hake, MD
|
|
Give Review
Ann Marie M. Hake works in the field of Neurology. He attended Creighton University School of Medicine. Creighton University School of Medicine is ranked 79 in research and 78 in primary care medicine Ann Marie M. Hake, MD is also a published doctor. He has 22 paper published. The most recent paper is: Connecting research discovery with care delivery in dementia: the development of the Indianapolis Discovery Network for Dementia.
Publications
- Connecting research discovery with care delivery in Dementia: the development of the Indianapolis Discovery Network for Dementia.
- On the horizon: pathways for drug development in Alzheimer's Disease.
- Visual function in Huntington's Disease patients and presymptomatic gene carriers.
- The treatment of Alzheimer's Disease: the approach from a clinical specialist in the trenches.
- Weight loss and incident Dementia in elderly Yoruba Nigerians: a 10-year follow-up study.
- Implementing innovative models of Dementia care: The Healthy Aging Brain Center.
- Incidence and risk factors for cognitive impairment no Dementia and mild cognitive impairment in African Americans.
- Accelerated weight loss and incident Dementia in an elderly African-American cohort.
- Efficacy and safety of galantamine in patients with Dementia with Lewy bodies: a 24-week open-label study.
- A phase I study of AIT-082 in healthy elderly volunteers.
- The use of memantine in Dementia with Lewy bodies.
- New concepts in the drug therapy of Alzheimer''s Disease.
- Response of patients with Alzheimer Disease to rivastigmine treatment is predicted by the rate of Disease progression.
- Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's Disease.
- Association of an interleukin 1 alpha polymorphism with Alzheimer's Disease.
- Alpha2 macroglobulin and the risk of Alzheimer's Disease.
- A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer''s Disease patients.
- Estrogen for Alzheimer's Disease in women: randomized, double-blind, placebo-controlled trial.
- Early-onset Alzheimer Disease caused by a new mutation (V717L) in the amyloid precursor protein gene.
- Use of cholinesterase inhibitors for treatment of Alzheimer Disease.
- Use of anticholinergics and the risk of cognitive impairment in an African American population.
Schools
Creighton University School Of Medicine
Creighton University
Ri Hospital Brown University
In UIndiana Alzd Center
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Carpal Tunnel Syndrome
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Choice Plus POS II
- Cofinity PPO
- Commercial Insurance Company
- Emblem Health
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Indiana University -
Indiana University School of Medicine -
Brown University -
Creighton University School of Medicine
Hospital
-
IU Health Methodist Hospital -
Franciscan St. Francis Health - Indianapolis
Helpful Reviews
Similar Doctors
|
|
Dr. Valerie A. Purvin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam D. Comer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pawan K. Singh, MD |